ATYR
Atyr Pharma, Inc.
A San Diego biotech developing medicines from tRNA synthetases, the enzymes best known for building proteins inside cells. Its lead drug candidate, efzofitimod, targets fibrosis and inflammation, such as scarring of the lungs. Founded in 2005 by scientists Paul Schimmel and Xiang-Lei Yang, it grew out of their discovery that these enzymes also act outside cells as signaling molecules — a twist that gives the company its name, taken from tyrosyl-tRNA synthetase.
CUSIP: 002120202HealthcareUS1 holder
Total Value
$1.90M
Total Shares
587.4K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
